Ono Pharmaceutical Co., Ltd.
Clinical trials sponsored by Ono Pharmaceutical Co., Ltd., explained in plain language.
-
New drug could reduce Blood-Draws for polycythemia vera patients
Disease control Not yet recruitingThis study tests a new drug called sapablursen in 250 adults with polycythemia vera, a condition where the body makes too many red blood cells. The drug is added to standard treatment and aims to reduce the need for regular blood removal (phlebotomy) and improve fatigue. Particip…
Phase: PHASE3 • Sponsor: Ono Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 01, 2026 20:41 UTC
-
Taiwan study checks if Pre-Surgery drug combo helps lung cancer patients
Knowledge-focused Not yet recruitingThis study will look back at medical records of 100 adults in Taiwan with non-small cell lung cancer who received nivolumab plus chemotherapy before surgery. The goal is to see how well this treatment works and if it is safe. Researchers will check if the cancer disappears comple…
Sponsor: Ono Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:49 UTC